Home /Research /1O Dynamic circulating tumour DNA (ctDNA) response to neoadjuvant (NA) atezolizumab (atezo) and surgery (surg) and association with outcomes in patients (pts) with NSCLC
SURGICAL

1O Dynamic circulating tumour DNA (ctDNA) response to neoadjuvant (NA) atezolizumab (atezo) and surgery (surg) and association with outcomes in patients (pts) with NSCLC

Mark G. Kris, Jessica M. Grindheim, Jamie E. Chaft, J.M. Lee, Bruce E. Johnson, Valerie W. Rusch, Paul A. Bunn, Harvey I. Pass, E. Schum, Jennifer W. Carlisle, M. Weyant, A. Nicholas, Ann Johnson, D. Shames, Ignacio I. Wistuba, David P. Carbone, Katja Schulze, David J. Kwiatkowski

Year
2021
Citations
35

Keywords

MedicineAtezolizumabOncologyInternal medicineNeoadjuvant therapyCancerImmunotherapyPembrolizumabBreast cancer

Related papers

Browse all SURGICAL papers